Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Last $5.57 USD
Change Today -0.27 / -4.62%
Volume 375.1K
NEO On Other Exchanges
As of 8:10 PM 02/12/16 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

12701 Commonwealth Drive

Suite 9

Fort Myers, FL 33913

United States

Phone: 239-768-0600

Fax: 239-690-4237

NeoGenomics, Inc. operates a network of cancer-focused genetic testing laboratories. The company has laboratory locations in Ft. Myers and Tampa, Florida; Fresno, Irvine, and West Sacramento, California; and Nashville, Tennessee. Testing Services The company offers the following types of testing services: Cytogenetics: The study of normal and abnormal chromosomes and their relationship to disease. It involves looking at the chromosome structure to identify changes from patterns seen in normal chromosomes. Cytogenetic studies are utilized to answer diagnostic, prognostic and predictive questions in the treatment of hematological malignancies. Fluorescence In-Situ Hybridization (FISH): A branch of cancer genetics that focuses on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes. FISH helps bridge abnormality detection between the chromosomal and DNA sequence levels. Fluorescence microscopy is used to visualize the fluorescent probes bound to the chromosomes. FISH could be used to help identify various gene alternations, such as amplification, deletions, and translocations. Flow Cytometry: A way to measure the characteristics of cell populations. Cells from peripheral blood, bone marrow aspirate, lymph nodes, and other areas are labeled with selective fluorescent antibodies and analyzed as they flow in a fluid stream through a beam of light. The properties measured in these antibodies include the relative size, relative granularity or internal complexity, and relative fluorescence intensity. These fluorescent antibodies bind to specific cell surface antigens and are used to identify malignant cell populations. Flow cytometry is performed in diagnosing various leukemia and lymphoma neoplasms. Flow cytometry is also used to monitor patients through therapy to determine whether the disease burden is increasing or decreasing, otherwise known as minimal residual disease monitoring. Immunohistochemistry (IHC): Refers to the process of localizing proteins in cells of a tissue section and relies on the principle of antibodies binding primarily to antigens in biological tissues. IHC is used in the diagnosis of abnormal cells, such as those found in cancerous tumors. Specific surface cytoplasmic or nuclear markers are characteristic of cellular events, such as proliferation or cell death (apoptosis). IHC is also used to understand the distribution and localization of differentially expressed proteins. Molecular Testing: An improving cancer diagnostic tool focusing on the analysis of DNA and RNA, as well as the structure and function of genes at the molecular level. Molecular testing employs multiple technologies, including DNA fragment length analysis, real-time polymerase chain reaction RNA analysis, bi-directional Sanger sequencing analysis, and next-generation sequencing. Pathology consultation services are when the company’s pathologists review surgical samples on a consultative basis for its clients. The company is one of a few laboratories in the country with an electron microscopy lab, which enables the company to analyze complex renal cases. The cancer testing services that the company offers to community-based pathologists are designed to be a natural extension of, and complementary to, the services that they perform within their own practices. In 2013, the company announced an exclusive five-year alliance with Covance Central Laboratories (Covance) to provide anatomic pathology, histology and specialty laboratory testing services for clinical trials. Covance is the major contract research organization servicing the needs of the pharmaceutical industry. Through this alliance, Covance’s clients would gain access to integrated anatomic pathology and histology services, including immunohistochemistry, fluorescence in-situ hybridization, and molecular testing. In addition to accessing the clinical trials market through the company’s relationship with Covance, the company also directly serves pharmaceutical companies. Global Service Offerings The company also offers a set of global services to meet the needs of those clients who are not credentialed a

Page 12Next Page

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEO:US $5.57 USD -0.27

NEO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cancer Genetics Inc $2.27 USD +0.20
Enzo Biochem Inc $4.30 USD -0.07
Foundation Medicine Inc $14.22 USD +0.08
Psychemedics Corp $11.09 USD +0.66
Rosetta Genomics Ltd $0.80 USD +0.01
View Industry Companies

Industry Analysis


Industry Average

Valuation NEO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.5x
Price/Book 5.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.0x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NEOGENOMICS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at